Our latest Investing Matters Podcast episode with QuotedData's Edward Marten has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Second Price Monitoring Extn

19 Oct 2020 11:06

RNS Number : 4854C
Midatech Pharma PLC
19 October 2020
 

Second Price Monitoring Extension

A second and final Price Monitoring Extension has been activated in this security. The auction call period is extended in this security for a further 5 minutes.

Following the first price monitoring extension this security would still have executed more than a pre-determined percentage above or below the price of the most recent automated execution today. London Stock Exchange electronic order book users have a final opportunity to review the prices and sizes of orders entered in this security prior to the auction execution.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
APMGZMMGGLKGGZM
Date   Source Headline
10th Mar 20235:52 pmRNSFurther re: Notice of General Meeting
8th Mar 20237:00 amRNSPosting of Circular and Notice of General Meeting
17th Feb 20237:00 amRNSHolding(s) in Company
16th Feb 20237:00 amRNSHolding(s) in Company
15th Feb 20232:49 pmRNSHolding(s) in Company
15th Feb 20231:36 pmRNSHolding(s) in Company
15th Feb 20231:26 pmRNSHolding(s) in Company
15th Feb 20238:05 amRNSClosing of $6.0m Private Placement & Broker Change
9th Feb 20235:10 pmRNSPrivate Placement Raising US$6.0 million
3rd Feb 20239:57 amRNSReceipt of NASDAQ Notice
23rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
23rd Jan 20234:35 pmRNSPrice Monitoring Extension
23rd Jan 202312:00 pmRNSResult of General Meeting
16th Jan 202311:24 amRNSHolding(s) in Company
12th Jan 20237:00 amRNSPlanned Dose Escalation in MTX-110 Phase 1 Study
6th Jan 20237:00 amRNSPosting of Circular and Notice of General Meeting
19th Dec 202212:06 pmRNSHolding(s) in Company
19th Dec 202210:48 amRNSHolding(s) in Company
19th Dec 20227:00 amRNSClosing of Offering, Revised Terms, AIM & Webinar
14th Dec 20222:05 pmRNSSecond Price Monitoring Extn
14th Dec 20222:00 pmRNSPrice Monitoring Extension
13th Dec 20224:40 pmRNSSecond Price Monitoring Extn
13th Dec 20224:35 pmRNSPrice Monitoring Extension
13th Dec 20223:22 pmRNSProposed Acquisition of Bioasis Technologies Inc
14th Nov 20227:00 amRNSFirst Patient Enrolled in Phase 1 Study of MTX-110
18th Oct 20227:00 amRNSReceipt of NASDAQ Notification
20th Sep 202211:51 amRNSHolding(s) in Company
14th Sep 20221:57 pmRNSADR Ratio Change
14th Sep 20227:00 amRNSInterim results for the six months to 30 June 2022
21st Jun 20227:00 amRNSMTX110 Development for the Treatment of Glioma
20th Jun 20225:58 pmRNSDirectorate Change
20th Jun 20222:33 pmRNSResult of 2022 Annual General Meeting
10th Jun 20227:00 amRNSRetirement of Chairman and Proposed New Chairman
10th Jun 20227:00 amRNSMTX110 Study to be Presented at ISPNO 2022
1st Jun 202212:23 pmRNSFast Track Designation for MTX110 Development
24th May 202211:09 amRNSPosting of Annual Report & Notice of AGM
27th Apr 20221:00 pmRNSIssue of Equity for Employee Share Incentive Plan
26th Apr 20227:00 amRNSResults for the Year Ended 31 December 2021
14th Apr 202212:37 pmRNSReceipt of NASDAQ Notice
17th Mar 20227:00 amRNSExercise of Warrants and Issue of Equity
9th Mar 20227:00 amRNSR&D collaboration with Janssen on second molecule
8th Mar 20229:30 amRNSAppointment of Nominated and Financial Adviser
9th Feb 20221:53 pmRNSHolding(s) in Company
18th Jan 20224:18 pmRNSHolding(s) in Company
17th Jan 20227:00 amRNSExtension of Janssen collaboration re Q-Sphera
7th Jan 20225:37 pmRNSHolding(s) in Company
13th Dec 20219:43 amRNSIND Application for MTX110 Study in GBM Effective
3rd Dec 20217:00 amRNSMidatech presenting at MelloMonday
24th Nov 20217:00 amRNSMidatech presenting at the Shares/AJ Bell Webinar
17th Sep 20219:31 amRNSInterim results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.